Melanocytic Nevi as Biomarkers of Breast Cancer Risk

article has not abstract

Vyšlo v časopise: Melanocytic Nevi as Biomarkers of Breast Cancer Risk. PLoS Med 11(6): e32767. doi:10.1371/journal.pmed.1001661
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001661

Souhrn

article has not abstract

Zdroje

1. ZhangM, ZhangX, QureshiA, EliassenH, HankinsonS, et al. (2014) Association between cutaneous nevi and breast cancer in the Nurses' Health Study: a prospective cohort study. PLoS Med 11: e1001659.

2. KvaskoffM, BijonA, MesrineS, VilierA, BagliettoL, et al. (2014) Association between melanocytic nevi and risk of breast diseases: the French E3N prospective cohort. PLoS Med 11: e1001660.

3. GreenA, SwerdlowAJ (1989) Epidemiology of melanocytic nevi. Epidemiol Rev 11 : 204–221.

4. GandiniS, SeraF, CattaruzzaMS, PasquiniP, AbeniD, et al. (2005) Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41 : 28–44.

5. GrichnikJM, RossAL, SchneiderSL, SanchezMI, EllerMS, et al. (2014) How, and from which cell sources, do nevi really develop? Exp Dermatol 23 : 310–313.

6. BlanpainC (2013) Tracing the cellular origin of cancer. Nat Cell Biol 15 : 126–134.

7. YagerJD, DavidsonNE (2006) Estrogen carcinogenesis in breast cancer. New Engl J Med 354 : 270–282.

8. MacKieRM, EnglishJ, AitchisonTC, FitzsimonsCP, WilsonP (1985) The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Brit J Dermatol 113 : 167–174.

9. SanchezJL, FigueroaLD, RodriguezE (1984) Behavior of melanocytic nevi during pregnancy. The Am J Dermatopath 6: S89–S91.

10. ChaudhuriPK, WalkerMJ, BrieleHA, BeattieCW, GuptaTK (1980) Incidence of estrogen receptor in benign nevi and human malignant melanoma. JAMA 244 : 791–793.

11. SnellRS, BischitzPG (1960) The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. J Invest Dermatol 35 : 73–82.

12. KvaskoffM, HanJ, QureshiAA, MissmerSA (2014) Pigmentary traits, family history of melanoma and the risk of endometriosis: a cohort study of US women. Int J Epidemiol 43 : 255–263.

13. GorlinRJ, KoutlasIG (1998) Multiple schwannomas, multiple nevi, and multiple vaginal leiomyomas: a new dominant syndrome. Am J Med Genet 78 : 76–81.

14. FreedmanAN, SeminaraD, GailMH, HartgeP, ColditzGA, et al. (2005) Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer I 97 : 715–723.

15. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch (2013) Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) DevCan database: “SEER 18 Incidence and Mortality, 2000–2010, with Kaposi Sarcoma and Mesothelioma.” Based on the November 2012 submission. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).

16. BuettnerPG, GarbeC (2000) Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination. Am J Epidemiol 151 : 72–77.